Korean Journal of Radiology

  • 제20권5호
  • /
  • Pages.739-748
  • /
  • 2019
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Current Opinion on Endovascular Therapy for Emergent Large Vessel Occlusion Due to Underlying Intracranial Atherosclerotic Stenosis

  • Dong-Hun Kang (Department of Neurosurgery, School of Medicine, Kyungpook National University) ;
  • Woong Yoon (Department of Radiology, Chonnam National University Medical School)
  • 투고 : 2018.11.22
  • 심사 : 2019.01.20
  • 발행 : 2019.05.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

For recanalization of emergent large vessel occlusions (ELVOs), endovascular therapy (EVT) using newer devices, such as a stent retriever and large-bore catheter, has shown better patient outcomes compared with intravenous recombinant tissue plasminogen activator only. Intracranial atherosclerotic stenosis (ICAS) is a major cause of acute ischemic stroke, the incidence of which is rising worldwide. Thus, it is not rare to encounter underlying ICAS during EVT procedures, particularly in Asian countries. ELVO due to underlying ICAS is often related to EVT procedure failure or complications, which can lead to poor functional recovery. However, information regarding EVT for this type of stroke is lacking because large clinical trials have been largely based on Western populations. In this review, we discuss the unique pathologic basis of ELVO with underlying ICAS, which may complicate EVT procedures. Moreover, we review EVT data for patients with ELVO due to underlying ICAS and suggest an optimal endovascular recanalization strategy based on the existing literature. Finally, we present future perspectives on this subject.

키워드

참고문헌

  1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1588 https://doi.org/10.1056/NEJM199512143332401
  2. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329 https://doi.org/10.1056/NEJMoa0804656
  3. Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254-2258 https://doi.org/10.1161/STROKEAHA.110.592535
  4. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86 https://doi.org/10.1002/ana.410320113
  5. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al.; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20 https://doi.org/10.1056/NEJMoa1411587
  6. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al.; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009-1018 https://doi.org/10.1056/NEJMoa1414792
  7. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al.; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019-1030 https://doi.org/10.1056/NEJMoa1414905
  8. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al.; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296-2306 https://doi.org/10.1056/NEJMoa1503780
  9. Kim YD, Cha MJ, Kim J, Lee DH, Lee HS, Nam CM, et al. Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation. Stroke 2011;42:930-934 https://doi.org/10.1161/STROKEAHA.110.602987
  10. Bang OY. Intracranial atherosclerosis: current understanding and perspectives. J Stroke 2014;16:27-35 https://doi.org/10.5853/jos.2014.16.1.27
  11. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396-2399 https://doi.org/10.1161/STROKEAHA.107.505776
  12. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874
  13. Kim JS, Bonovich D. Research on intracranial atherosclerosis from the East and West: why are the results different? J Stroke 2014;16:105-113 https://doi.org/10.5853/jos.2014.16.3.105
  14. Kim BM. Causes and solutions of endovascular treatment failure. J Stroke 2017;19:131-142 https://doi.org/10.5853/jos.2017.00283
  15. Hwang YH, Kim YW, Kang DH, Kim YS, Liebeskind DS. Impact of target arterial residual stenosis on outcome after endovascular revascularization. Stroke 2016;47:1850-1857 https://doi.org/10.1161/STROKEAHA.116.013046
  16. Leung SY, Ng TH, Yuen ST, Lauder IJ, Ho FC. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 1993;24:779-786 https://doi.org/10.1161/01.STR.24.6.779
  17. Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, et al.; CICAS Study Group. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) study. Stroke 2014;45:663-669 https://doi.org/10.1161/STROKEAHA.113.003508
  18. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among Whites, Blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005;111:1327-1331 https://doi.org/10.1161/01.CIR.0000157736.19739.D0
  19. Lee JS, Hong JM, Lee KS, Suh HI, Demchuk AM, Hwang YH, et al. Endovascular therapy of cerebral arterial occlusions: intracranial atherosclerosis versus embolism. J Stroke Cerebrovasc Dis 2015;24:2074-2080 https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.05.003
  20. Yoon W, Kim SK, Park MS, Kim BC, Kang HK. Endovascular treatment and the outcomes of atherosclerotic intracranial stenosis in patients with hyperacute stroke. Neurosurgery 2015;76:680-686; discussion 686 https://doi.org/10.1227/NEU.0000000000000694
  21. Kang DH, Kim YW, Hwang YH, Park SP, Kim YS, Baik SK. Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban. Cerebrovasc Dis 2014;37:350-355 https://doi.org/10.1159/000362435
  22. Kim YW, Hong JM, Park DG, Choi JW, Kang DH, Kim YS, et al. Effect of intracranial atherosclerotic disease on endovascular treatment for patients with acute vertebrobasilar occlusion. AJNR Am J Neuroradiol 2016;37:2072-2078 https://doi.org/10.3174/ajnr.A4844
  23. Kim SJ, Ryoo S, Kim GM, Chung CS, Lee KH, Bang OY. Clinical and radiological outcomes after intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. Cerebrovasc Dis 2011;31:427-434 https://doi.org/10.1159/000323610
  24. Kim SJ, Seok JM, Bang OY, Kim GM, Kim KH, Jeon P, et al. MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab 2009;29:1138-1145 https://doi.org/10.1038/jcbfm.2009.38
  25. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007;115:2969-2975 https://doi.org/10.1161/CIRCULATIONAHA.106.622464
  26. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804 https://doi.org/10.1146/annurev.ph.57.030195.004043
  27. Velican C, Velican D. Atherosclerotic involvement of human intracranial arteries with special reference to intimal necrosis. Atherosclerosis 1982;43:59-69 https://doi.org/10.1016/0021-9150(82)90099-5
  28. Velican C, Anghelescu M, Velican D. Preliminary study on the natural history of cerebral atherosclerosis. Med Interne 1981;19:137-145
  29. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al.; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316 https://doi.org/10.1056/NEJMoa043033
  30. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al.; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993-1003 https://doi.org/10.1056/NEJMoa1105335
  31. Lee JS, Hong JM, Kim JS. Diagnostic and therapeutic strategies for acute intracranial atherosclerosis-related occlusions. J Stroke 2017;19:143-151 https://doi.org/10.5853/jos.2017.00626
  32. Kim SK, Yoon W, Kim TS, Kim HS, Heo TW, Park MS. Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 2015;36:1756-1762 https://doi.org/10.3174/ajnr.A4402
  33. Chen XY, Wong KS, Lam WW, Zhao HL, Ng HK. Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2008;25:74-80 https://doi.org/10.1159/000111525
  34. Suh HI, Hong JM, Lee KS, Han M, Choi JW, Kim JS, et al. Imaging predictors for atherosclerosis-related intracranial large artery occlusions in acute anterior circulation stroke. J Stroke 2016;18:352-354 https://doi.org/10.5853/jos.2016.00283
  35. Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005;36:2379-2383 https://doi.org/10.1161/01.STR.0000185932.73486.7a
  36. Cho KH, Yoon Y, Sohn SI, Kim JS. Susceptibility vessel signs on T2*-weighted gradient echo images in patients with cerebral atherosclerosis. Int J Stroke 2014;9:E32
  37. Lee JS, Hong JM, Lee KS, Suh HI, Choi JW, Kim SY. Primary stent retrieval for acute intracranial large artery occlusion due to atherosclerotic disease. J Stroke 2016;18:96-101 https://doi.org/10.5853/jos.2015.01347
  38. Baek JH, Kim BM, Kim DJ, Heo JH, Nam HS, Song D, et al. Importance of truncal-type occlusion in stentriever-based thrombectomy for acute stroke. Neurology 2016;87:1542-1550 https://doi.org/10.1212/WNL.0000000000003202
  39. Manning NW, Chapot R, Meyers PM. Endovascular stroke management: key elements of success. Cerebrovasc Dis 2016;42:170-177 https://doi.org/10.1159/000445449
  40. Yoon W, Kim SK, Park MS, Baek BH, Lee YY. Predictive factors for good outcome and mortality after stent-retriever thrombectomy in patients with acute anterior circulation stroke. J Stroke 2017;19:97-103 https://doi.org/10.5853/jos.2016.00675
  41. Lapergue B, Blanc R, Gory B, Labreuche J, Duhamel A, Marnat G, et al.; ASTER Trial Investigators. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA 2017;318:443-452 https://doi.org/10.1001/jama.2017.9644
  42. Kang DH, Park J. Endovascular stroke therapy focused on stent retriever thrombectomy and direct clot aspiration: historical review and modern application. J Korean Neurosurg Soc 2017;60:335-347 https://doi.org/10.3340/jkns.2016.0809.005
  43. Gory B, Mazighi M, Blanc R, Labreuche J, Piotin M, Turjman F, et al. Mechanical thrombectomy in basilar artery occlusion: influence of reperfusion on clinical outcome and impact of the first-line strategy (ADAPT vs stent retriever). J Neurosurg 2018;129:1482-1491 https://doi.org/10.3171/2017.7.JNS171043
  44. Stapleton CJ, Leslie-Mazwi TM, Torok CM, Hakimelahi R, Hirsch JA, Yoo AJ, et al. A direct aspiration first-pass technique vs stentriever thrombectomy in emergent large vessel intracranial occlusions. J Neurosurg 2018;128:567-574 https://doi.org/10.3171/2016.11.JNS161563
  45. Al Kasab S, Almadidy Z, Spiotta AM, Turk AS, Chaudry MI, Hungerford JP, et al. Endovascular treatment for AIS with underlying ICAD. J Neurointerv Surg 2017;9:948-951 https://doi.org/10.1136/neurintsurg-2016-012529
  46. Lee YY, Yoon W, Kim SK, Baek BH, Kim GS, Kim JT, et al. Acute basilar artery occlusion: differences in characteristics and outcomes after endovascular therapy between patients with and without underlying severe atherosclerotic stenosis. AJNR Am J Neuroradiol 2017;38:1600-1604 https://doi.org/10.3174/ajnr.A5233
  47. Baik SK, Oh SJ, Park KP, Lee JH. Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke. Interv Neuroradiol 2011;17:442-451 https://doi.org/10.1177/159101991101700408
  48. Fiorella D, Derdeyn CP, Lynn MJ, Barnwell SL, Hoh BL, Levy EI, et al.; SAMMPRIS Trial Investigators. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012;43:2682-2688 https://doi.org/10.1161/STROKEAHA.112.661173
  49. Kang DH, Yoon W, Kim SK, Baek BH, Lee YY, Kim YW, et al. Endovascular treatment for emergent large vessel occlusion due to severe intracranial atherosclerotic stenosis. J Neurosurg 2018 Jun 1 [Epub ahead of print]. https://doi.org/10.3171/2018.1.JNS172350
  50. Baek JH, Kim BM, Kim DJ, Heo JH, Nam HS, Yoo J. Stenting as a rescue treatment after failure of mechanical thrombectomy for anterior circulation large artery occlusion. Stroke 2016;47:2360-2363 https://doi.org/10.1161/STROKEAHA.116.014073
  51. Chang Y, Kim BM, Bang OY, Baek JH, Heo JH, Nam HS, et al. Rescue stenting for failed mechanical thrombectomy in acute ischemic stroke: a multicenter experience. Stroke 2018;49:958-964
  52. Leung TW, Wang L, Soo YOY, Ip VHL, Chan AYY, Au LWC, et al. Evolution of intracranial atherosclerotic disease under modern medical therapy. Ann Neurol 2015;77:478-486 https://doi.org/10.1002/ana.24340